Global Autoimmune Disease Therapeutics Market (2019-2025)

July 2019 | 269 pages | ID: G3E9ECB50DDEN
KBV Research

Abstracts

The Global Autoimmune Disease Therapeutics Market size is expected to reach $149.4 billion by 2025, rising at a market growth of 4.34% CAGR during the forecast period.

The autoimmune disease therapeutics market is anticipated to experience significant market growth during the forecast period due to early diagnosis of the disease, the latest launch of advanced therapy, and increased incidence of autoimmune disease. The market is witnessing a strong presence of late-stage pipeline drugs such as tocilizumab, baricitinib, olokizumab, apremilast, abatacept, PF-06438179, golimumab, ustekinumab, etrolizumab, tofacitinib, and others. On the other hand, higher costs associated with sophisticated therapy are anticipated to hamper the market growth.

Autoimmune diseases happen when an individual's body's immune system treats and attacks healthy cells of his/her own body as foreign cells. These diseases trigger differences in the functioning of the organ, abnormal organ growth, and destruction of healthy body tissues. Autoimmune diseases are usually chronic and there's no curative treatment for them. Dermatomyositis, Hashimoto's disease of type 1 diabetes, Sjogren's syndrome, Psoriasis are some examples of autoimmune diseases. Systemic treatment of autoimmune diseases and localized treatment of autoimmune disease are two kinds of treatments for autoimmune disease.

Based on Indication, the market is segmented into Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, and Other Indications. Based on Drug Class, the market is segmented into Anti-Inflammatory, Anti-Hyperglycemics, NSAIDs (Nonsteroidal anti-inflammatory drugs), Interferons and Other Drugs. Based on the Distribution Channel, the market is segmented into Hospital Pharmacy, Online and Retail Pharmacies & Drug Stores. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, Bio-Rad Laboratories, Inc., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, AbbVie, Inc., Amgen, Inc. and Novartis AG.

Scope of the Study

Market Segmentation:

By Indication

• Rheumatic Disease
• Diabetes
• Multiple Sclerosis
• Inflammatory Bowel Disease
• Other Indications

By Drug Class

• Anti-Inflammatory
• Anti-Hyperglycemics
• NSAIDs
• Interferons
• Other Drugs

By Distribution Channel

• Hospital Pharmacy
• Online
• Retail Pharmacies and Drug Stores

By Geography

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific
• LAMEA
• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Companies Profiled

• ABBOTT Laboratories
• Bio-Rad Laboratories, Inc.
• Johnson and Johnson
• GlaxoSmithKline PLC (GSK)
• Pfizer, Inc.
• Merck & Co., Inc.
• Bayer AG
• AbbVie, Inc.
• Amgen, Inc.
• Novartis AG

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Contents

CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 Global Autoimmune Disease Therapeutics Market, by Indication
  1.4.2 Global Autoimmune Disease Therapeutics Market, by Drug Class
  1.4.3 Global Autoimmune Disease Therapeutics Market, by Distribution Channel
  1.4.4 Global Autoimmune Disease Therapeutics Market, by Geography
1.5 Methodology for the research

CHAPTER 2. MARKET OVERVIEW

2.1 Introduction
  2.1.1 Overview
  2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
  2.2.1 Market Drivers
  2.2.2 Market Restraints

CHAPTER 3. GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION

3.1 Global Rheumatic Disease Market by Region
3.2 Global Diabetes Market by Region
3.3 Global Multiple Sclerosis Market by Region
3.4 Global Inflammatory Bowel Disease Market by Region
3.5 Global Other Indications Market by Region

CHAPTER 4. GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS

4.1 Global Anti-Inflammatory Market by Region
4.2 Global Anti-Hyperglycemics Market by Region
4.3 Global NSAIDs Market by Region
4.4 Global Interferons Market by Region
4.5 Global Other Drugs Market by Region

CHAPTER 5. GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL

5.1 Global Hospital Pharmacy Market by Region
5.2 Global Online Market by Region
5.3 Global Retail Pharmacies and Drug Stores Market by Region

CHAPTER 6. GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY REGION

6.1 North America Autoimmune Disease Therapeutics Market
  6.1.1 North America Autoimmune Disease Therapeutics Market by Indication
    6.1.1.1 North America Rheumatic Disease Market by Country
    6.1.1.2 North America Diabetes Market by Country
    6.1.1.3 North America Multiple Sclerosis Market by Country
    6.1.1.4 North America Inflammatory Bowel Disease Market by Country
    6.1.1.5 North America Other Indications Market by Country
  6.1.2 North America Autoimmune Disease Therapeutics Market by Drug Class
    6.1.2.1 North America Anti-Inflammatory Market by Country
    6.1.2.2 North America Anti-Hyperglycemics Market by Country
    6.1.2.3 North America NSAIDs Market by Country
    6.1.2.4 North America Interferons Market by Country
    6.1.2.5 North America Other Drugs Market by Country
  6.1.3 North America Autoimmune Disease Therapeutics Market by Distribution Channel
    6.1.3.1 North America Hospital Pharmacy Market by Country
    6.1.3.2 North America Online Market by Country
    6.1.3.3 North America Retail Pharmacies and Drug Stores Market by Country
  6.1.4 North America Autoimmune Disease Therapeutics Market by Country
    6.1.4.1 USA Autoimmune Disease Therapeutics Market
      6.1.4.1.1 USA Autoimmune Disease Therapeutics Market by Indication
      6.1.4.1.2 USA Autoimmune Disease Therapeutics Market by Drug Class
      6.1.4.1.3 USA Autoimmune Disease Therapeutics Market by Distribution Channel
    6.1.4.2 Canada Autoimmune Disease Therapeutics Market
      6.1.4.2.1 Canada Autoimmune Disease Therapeutics Market by Indication
      6.1.4.2.2 Canada Autoimmune Disease Therapeutics Market by Drug Class
      6.1.4.2.3 Canada Autoimmune Disease Therapeutics Market by Distribution Channel
    6.1.4.3 Mexico Autoimmune Disease Therapeutics Market
      6.1.4.3.1 Mexico Autoimmune Disease Therapeutics Market by Indication
      6.1.4.3.2 Mexico Autoimmune Disease Therapeutics Market by Drug Class
      6.1.4.3.3 Mexico Autoimmune Disease Therapeutics Market by Distribution Channel
    6.1.4.4 Rest of North America Autoimmune Disease Therapeutics Market
      6.1.4.4.1 Rest of North America Autoimmune Disease Therapeutics Market by Indication
      6.1.4.4.2 Rest of North America Autoimmune Disease Therapeutics Market by Drug Class
      6.1.4.4.3 Rest of North America Autoimmune Disease Therapeutics Market by Distribution Channel
6.2 Europe Autoimmune Disease Therapeutics Market
  6.2.1 Europe Autoimmune Disease Therapeutics Market by Indication
    6.2.1.1 Europe Rheumatic Disease Market by Country
    6.2.1.2 Europe Diabetes Market by Country
    6.2.1.3 Europe Multiple Sclerosis Market by Country
    6.2.1.4 Europe Inflammatory Bowel Disease Market by Country
    6.2.1.5 Europe Other Indications Market by Country
  6.2.2 Europe Autoimmune Disease Therapeutics Market by Drug Class
    6.2.2.1 Europe Anti-Inflammatory Market by Country
    6.2.2.2 Europe Anti-Hyperglycemics Market by Country
    6.2.2.3 Europe NSAIDs Market by Country
    6.2.2.4 Europe Interferons Market by Country
    6.2.2.5 Europe Other Drugs Market by Country
  6.2.3 Europe Autoimmune Disease Therapeutics Market by Distribution Channel
    6.2.3.1 Europe Hospital Pharmacy Market by Country
    6.2.3.2 Europe Online Market by Country
    6.2.3.3 Europe Retail Pharmacies and Drug Stores Market by Country
  6.2.4 Europe Autoimmune Disease Therapeutics Market by Country
    6.2.4.1 Germany Autoimmune Disease Therapeutics Market
      6.2.4.1.1 Germany Autoimmune Disease Therapeutics Market by Indication
      6.2.4.1.2 Germany Autoimmune Disease Therapeutics Market by Drug Class
      6.2.4.1.3 Germany Autoimmune Disease Therapeutics Market by Distribution Channel
    6.2.4.2 UK Autoimmune Disease Therapeutics Market
      6.2.4.2.1 UK Autoimmune Disease Therapeutics Market by Indication
      6.2.4.2.2 UK Autoimmune Disease Therapeutics Market by Drug Class
      6.2.4.2.3 UK Autoimmune Disease Therapeutics Market by Distribution Channel
    6.2.4.3 France Autoimmune Disease Therapeutics Market
      6.2.4.3.1 France Autoimmune Disease Therapeutics Market by Indication
      6.2.4.3.2 France Autoimmune Disease Therapeutics Market by Drug Class
      6.2.4.3.3 France Autoimmune Disease Therapeutics Market by Distribution Channel
    6.2.4.4 Russia Autoimmune Disease Therapeutics Market
      6.2.4.4.1 Russia Autoimmune Disease Therapeutics Market by Indication
      6.2.4.4.2 Russia Autoimmune Disease Therapeutics Market by Drug Class
      6.2.4.4.3 Russia Autoimmune Disease Therapeutics Market by Distribution Channel
    6.2.4.5 Spain Autoimmune Disease Therapeutics Market
      6.2.4.5.1 Spain Autoimmune Disease Therapeutics Market by Indication
      6.2.4.5.2 Spain Autoimmune Disease Therapeutics Market by Drug Class
      6.2.4.5.3 Spain Autoimmune Disease Therapeutics Market by Distribution Channel
    6.2.4.6 Italy Autoimmune Disease Therapeutics Market
      6.2.4.6.1 Italy Autoimmune Disease Therapeutics Market by Indication
      6.2.4.6.2 Italy Autoimmune Disease Therapeutics Market by Drug Class
      6.2.4.6.3 Italy Autoimmune Disease Therapeutics Market by Distribution Channel
    6.2.4.7 Rest of Europe Autoimmune Disease Therapeutics Market
      6.2.4.7.1 Rest of Europe Autoimmune Disease Therapeutics Market by Indication
      6.2.4.7.2 Rest of Europe Autoimmune Disease Therapeutics Market by Drug Class
      6.2.4.7.3 Rest of Europe Autoimmune Disease Therapeutics Market by Distribution Channel
6.3 Asia Pacific Autoimmune Disease Therapeutics Market
  6.3.1 Asia Pacific Autoimmune Disease Therapeutics Market by Indication
    6.3.1.1 Asia Pacific Rheumatic Disease Market by Country
    6.3.1.2 Asia Pacific Diabetes Market by Country
    6.3.1.3 Asia Pacific Multiple Sclerosis Market by Country
    6.3.1.4 Asia Pacific Inflammatory Bowel Disease Market by Country
    6.3.1.5 Asia Pacific Other Indications Market by Country
  6.3.2 Asia Pacific Autoimmune Disease Therapeutics Market by Drug Class
    6.3.2.1 Asia Pacific Anti-Inflammatory Market by Country
    6.3.2.2 Asia Pacific Anti-Hyperglycemics Market by Country
    6.3.2.3 Asia Pacific NSAIDs Market by Country
    6.3.2.4 Asia Pacific Interferons Market by Country
    6.3.2.5 Asia Pacific Other Drugs Market by Country
  6.3.3 Asia Pacific Autoimmune Disease Therapeutics Market by Distribution Channel
    6.3.3.1 Asia Pacific Hospital Pharmacy Market by Country
    6.3.3.2 Asia Pacific Online Market by Country
    6.3.3.3 Asia Pacific Retail Pharmacies and Drug Stores Market by Country
  6.3.4 Asia Pacific Autoimmune Disease Therapeutics Market by Country
    6.3.4.1 China Autoimmune Disease Therapeutics Market
      6.3.4.1.1 China Autoimmune Disease Therapeutics Market by Indication
      6.3.4.1.2 China Autoimmune Disease Therapeutics Market by Drug Class
      6.3.4.1.3 China Autoimmune Disease Therapeutics Market by Distribution Channel
    6.3.4.2 Japan Autoimmune Disease Therapeutics Market
      6.3.4.2.1 Japan Autoimmune Disease Therapeutics Market by Indication
      6.3.4.2.2 Japan Autoimmune Disease Therapeutics Market by Drug Class
      6.3.4.2.3 Japan Autoimmune Disease Therapeutics Market by Distribution Channel
    6.3.4.3 India Autoimmune Disease Therapeutics Market
      6.3.4.3.1 India Autoimmune Disease Therapeutics Market by Indication
      6.3.4.3.2 India Autoimmune Disease Therapeutics Market by Drug Class
      6.3.4.3.3 India Autoimmune Disease Therapeutics Market by Distribution Channel
    6.3.4.4 South Korea Autoimmune Disease Therapeutics Market
      6.3.4.4.1 South Korea Autoimmune Disease Therapeutics Market by Indication
      6.3.4.4.2 South Korea Autoimmune Disease Therapeutics Market by Drug Class
      6.3.4.4.3 South Korea Autoimmune Disease Therapeutics Market by Distribution Channel
    6.3.4.5 Singapore Autoimmune Disease Therapeutics Market
      6.3.4.5.1 Singapore Autoimmune Disease Therapeutics Market by Indication
      6.3.4.5.2 Singapore Autoimmune Disease Therapeutics Market by Drug Class
      6.3.4.5.3 Singapore Autoimmune Disease Therapeutics Market by Distribution Channel
    6.3.4.6 Malaysia Autoimmune Disease Therapeutics Market
      6.3.4.6.1 Malaysia Autoimmune Disease Therapeutics Market by Indication
      6.3.4.6.2 Malaysia Autoimmune Disease Therapeutics Market by Drug Class
      6.3.4.6.3 Malaysia Autoimmune Disease Therapeutics Market by Distribution Channel
    6.3.4.7 Rest of Asia Pacific Autoimmune Disease Therapeutics Market
      6.3.4.7.1 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Indication
      6.3.4.7.2 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Drug Class
      6.3.4.7.3 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Distribution Channel
6.4 LAMEA Autoimmune Disease Therapeutics Market
  6.4.1 LAMEA Autoimmune Disease Therapeutics Market by Indication
    6.4.1.1 LAMEA Rheumatic Disease Market by Country
    6.4.1.2 LAMEA Diabetes Market by Country
    6.4.1.3 LAMEA Multiple Sclerosis Market by Country
    6.4.1.4 LAMEA Inflammatory Bowel Disease Market by Country
    6.4.1.5 LAMEA Other Indications Market by Country
  6.4.2 LAMEA Autoimmune Disease Therapeutics Market by Drug Class
    6.4.2.1 LAMEA Anti-Inflammatory Market by Country
    6.4.2.2 LAMEA Anti-Hyperglycemics Market by Country
    6.4.2.3 LAMEA NSAIDs Market by Country
    6.4.2.4 LAMEA Interferons Market by Country
    6.4.2.5 LAMEA Other Drugs Market by Country
  6.4.3 LAMEA Autoimmune Disease Therapeutics Market by Distribution Channel
    6.4.3.1 LAMEA Hospital Pharmacy Market by Country
    6.4.3.2 LAMEA Online Market by Country
    6.4.3.3 LAMEA Retail Pharmacies and Drug Stores Market by Country
  6.4.4 LAMEA Autoimmune Disease Therapeutics Market by Country
    6.4.4.1 Brazil Autoimmune Disease Therapeutics Market
      6.4.4.1.1 Brazil Autoimmune Disease Therapeutics Market by Indication
      6.4.4.1.2 Brazil Autoimmune Disease Therapeutics Market by Drug Class
      6.4.4.1.3 Brazil Autoimmune Disease Therapeutics Market by Distribution Channel
    6.4.4.2 Argentina Autoimmune Disease Therapeutics Market
      6.4.4.2.1 Argentina Autoimmune Disease Therapeutics Market by Indication
      6.4.4.2.2 Argentina Autoimmune Disease Therapeutics Market by Drug Class
      6.4.4.2.3 Argentina Autoimmune Disease Therapeutics Market by Distribution Channel
    6.4.4.3 UAE Autoimmune Disease Therapeutics Market
      6.4.4.3.1 UAE Autoimmune Disease Therapeutics Market by Indication
      6.4.4.3.2 UAE Autoimmune Disease Therapeutics Market by Drug Class
      6.4.4.3.3 UAE Autoimmune Disease Therapeutics Market by Distribution Channel
    6.4.4.4 Saudi Arabia Autoimmune Disease Therapeutics Market
      6.4.4.4.1 Saudi Arabia Autoimmune Disease Therapeutics Market by Indication
      6.4.4.4.2 Saudi Arabia Autoimmune Disease Therapeutics Market by Drug Class
      6.4.4.4.3 Saudi Arabia Autoimmune Disease Therapeutics Market by Distribution Channel
    6.4.4.5 South Africa Autoimmune Disease Therapeutics Market
      6.4.4.5.1 South Africa Autoimmune Disease Therapeutics Market by Indication
      6.4.4.5.2 South Africa Autoimmune Disease Therapeutics Market by Drug Class
      6.4.4.5.3 South Africa Autoimmune Disease Therapeutics Market by Distribution Channel
    6.4.4.6 Nigeria Autoimmune Disease Therapeutics Market
      6.4.4.6.1 Nigeria Autoimmune Disease Therapeutics Market by Indication
      6.4.4.6.2 Nigeria Autoimmune Disease Therapeutics Market by Drug Class
      6.4.4.6.3 Nigeria Autoimmune Disease Therapeutics Market by Distribution Channel
    6.4.4.7 Rest of LAMEA Autoimmune Disease Therapeutics Market
      6.4.4.7.1 Rest of LAMEA Autoimmune Disease Therapeutics Market by Indication
      6.4.4.7.2 Rest of LAMEA Autoimmune Disease Therapeutics Market by Drug Class
      6.4.4.7.3 Rest of LAMEA Autoimmune Disease Therapeutics Market by Distribution Channel

CHAPTER 7. COMPANY PROFILES

7.1 ABBOTT Laboratories
  7.1.1 Company Overview
  7.1.2 Financial Analysis
  7.1.3 Segmental and Regional Analysis
  7.1.4 Research & Development Expense
7.2 Bio-Rad Laboratories, Inc.
  7.2.1 Company Overview
  7.2.2 Financial Analysis
  7.2.3 Segmental and Regional Analysis
  7.2.4 Research & Development Expenses
7.3 Johnson and Johnson
  7.3.1 Company Overview
  7.3.2 Financial Analysis
  7.3.3 Segmental &Regional Analysis
  7.3.4 Research & Development Expenses
  7.3.1 Recent strategies and developments:
    7.3.1.1 Collaborations, partnerships and agreements:
7.4 GlaxoSmithKline PLC (GSK)
  7.4.1 Company Overview
  7.4.2 Financial Analysis
  7.4.3 Segmental and Regional Analysis
  7.4.4 Research & Development Expense
  7.4.5 Recent strategies and developments:
    7.4.5.1 Acquisition and mergers:
    7.4.5.2 Collaborations, partnerships and agreements:
    7.4.5.3 Product launches:
7.5 Pfizer, Inc.
  7.5.1 Company Overview
  7.5.2 Financial Analysis
  7.5.3 Segmental and Regional Analysis
  7.5.4 Research & Development Expense
  7.5.5 Recent strategies and developments:
    7.5.5.1 Collaborations, partnerships and agreements:
    7.5.5.2 Approval:
7.6 Merck & Co., Inc.
  7.6.1 Company Overview
  7.6.2 Financial Analysis
  7.6.3 Segmental and Regional Analysis
  7.6.4 Research & Development Expenses
  7.6.5 Recent strategies and developments:
    7.6.5.1 Collaborations, partnerships and agreements:
    7.6.5.2 Acquisition and mergers:
7.7 Bayer AG (Bayer Schering Pharma AG)
  7.7.1 Company Overview
  7.7.2 Financial Analysis
  7.7.3 Segmental and Regional Analysis
  7.7.4 Research & Development Expense
  7.7.5 Recent strategies and developments:
    7.7.5.1 Collaborations, partnerships and agreements:
7.8 AbbVie, Inc.
  7.8.1 Company Overview
  7.8.2 Financial Analysis
  7.8.3 Regional Analysis
  7.8.4 Research & Development Expense
  7.8.5 Recent strategies and developments:
    7.8.5.1 Collaborations, partnerships and agreements:
7.9 Amgen, Inc.
  7.9.1 Company overview
  7.9.2 Financial Analysis
  7.9.3 Regional Analysis
  7.9.4 Research & Development Expense
  7.9.5 Recent strategies and developments:
    7.9.5.1 Product launches:
    7.9.5.2 Collaborations, partnerships and agreements:
7.1 Novartis AG
  7.10.1 Company Overview
  7.10.2 Financial Analysis
  7.10.3 Segmental and Regional Analysis
  7.10.4 Research & Development Expense
  7.10.5 Recent strategies and developments:
    7.10.5.1 Acquisition and mergers:
    7.10.5.2 Collaborations, partnerships and agreements:

List Of Tables

LIST OF TABLES

TABLE 1 GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 2 GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 3 GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 4 GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 5 GLOBAL RHEUMATIC DISEASE MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 6 GLOBAL RHEUMATIC DISEASE MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 7 GLOBAL DIABETES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 8 GLOBAL DIABETES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 9 GLOBAL MULTIPLE SCLEROSIS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 10 GLOBAL MULTIPLE SCLEROSIS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 11 GLOBAL INFLAMMATORY BOWEL DISEASE MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 12 GLOBAL INFLAMMATORY BOWEL DISEASE MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 13 GLOBAL OTHER INDICATIONS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 14 GLOBAL OTHER INDICATIONS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 15 GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 16 GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 17 GLOBAL ANTI-INFLAMMATORY MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 18 GLOBAL ANTI-INFLAMMATORY MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 19 GLOBAL ANTI-HYPERGLYCEMICS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 20 GLOBAL ANTI-HYPERGLYCEMICS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 21 GLOBAL NSAIDS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 22 GLOBAL NSAIDS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 23 GLOBAL INTERFERONS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 24 GLOBAL INTERFERONS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 25 GLOBAL OTHER DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 26 GLOBAL OTHER DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 27 GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 28 GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 29 GLOBAL HOSPITAL PHARMACY MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 30 GLOBAL HOSPITAL PHARMACY MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 31 GLOBAL ONLINE MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 32 GLOBAL ONLINE MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 33 GLOBAL RETAIL PHARMACIES AND DRUG STORES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 34 GLOBAL RETAIL PHARMACIES AND DRUG STORES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 35 GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 36 GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 37 NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 38 NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 39 NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 40 NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 41 NORTH AMERICA RHEUMATIC DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 42 NORTH AMERICA RHEUMATIC DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 43 NORTH AMERICA DIABETES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 44 NORTH AMERICA DIABETES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 45 NORTH AMERICA MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 46 NORTH AMERICA MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 47 NORTH AMERICA INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 48 NORTH AMERICA INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 49 NORTH AMERICA OTHER INDICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 50 NORTH AMERICA OTHER INDICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 51 NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 52 NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 53 NORTH AMERICA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 54 NORTH AMERICA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 55 NORTH AMERICA ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 56 NORTH AMERICA ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 57 NORTH AMERICA NSAIDS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 58 NORTH AMERICA NSAIDS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 59 NORTH AMERICA INTERFERONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 60 NORTH AMERICA INTERFERONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 61 NORTH AMERICA OTHER DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 62 NORTH AMERICA OTHER DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 63 NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 64 NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 65 NORTH AMERICA HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 66 NORTH AMERICA HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 67 NORTH AMERICA ONLINE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 68 NORTH AMERICA ONLINE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 69 NORTH AMERICA RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 70 NORTH AMERICA RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 71 NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 72 NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 73 USA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 74 USA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 75 USA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 76 USA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 77 USA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 78 USA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 79 USA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 80 USA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 81 CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 82 CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 83 CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 84 CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 85 CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 86 CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 87 CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 88 CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 89 MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 90 MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 91 MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 92 MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 93 MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 94 MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 95 MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 96 MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 97 REST OF NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 98 REST OF NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 99 REST OF NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 100 REST OF NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 101 REST OF NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 102 REST OF NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 103 REST OF NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 104 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 105 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 106 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 107 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 108 EUROPE RHEUMATIC DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 109 EUROPE RHEUMATIC DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 110 EUROPE DIABETES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 111 EUROPE DIABETES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 112 EUROPE MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 113 EUROPE MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 114 EUROPE INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 115 EUROPE INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 116 EUROPE OTHER INDICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 117 EUROPE OTHER INDICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 118 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 119 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 120 EUROPE ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 121 EUROPE ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 122 EUROPE ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 123 EUROPE ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 124 EUROPE NSAIDS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 125 EUROPE NSAIDS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 126 EUROPE INTERFERONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 127 EUROPE INTERFERONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 128 EUROPE OTHER DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 129 EUROPE OTHER DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 130 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 131 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 132 EUROPE HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 133 EUROPE HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 134 EUROPE ONLINE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 135 EUROPE ONLINE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 136 EUROPE RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 137 EUROPE RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 138 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 139 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 140 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 141 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 142 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 143 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 144 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 145 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 146 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 147 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 148 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 149 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 150 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 151 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 152 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 153 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 154 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 155 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 156 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 157 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 158 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 159 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 160 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 161 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 162 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 163 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 164 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 165 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 166 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 167 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 168 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 169 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 170 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 171 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 172 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 173 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 174 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 175 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 176 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 177 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 178 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 179 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 180 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 181 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 182 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 183 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 184 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 185 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 186 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 187 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 188 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 189 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 190 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 191 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 192 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 193 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 194 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 195 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 196 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 197 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 198 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 199 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 200 ASIA PACIFIC RHEUMATIC DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 201 ASIA PACIFIC RHEUMATIC DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 202 ASIA PACIFIC DIABETES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 203 ASIA PACIFIC DIABETES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 204 ASIA PACIFIC MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 205 ASIA PACIFIC MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 206 ASIA PACIFIC INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 207 ASIA PACIFIC INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 208 ASIA PACIFIC OTHER INDICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 209 ASIA PACIFIC OTHER INDICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 210 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 211 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 212 ASIA PACIFIC ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 213 ASIA PACIFIC ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 214 ASIA PACIFIC ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 215 ASIA PACIFIC ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 216 ASIA PACIFIC NSAIDS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 217 ASIA PACIFIC NSAIDS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 218 ASIA PACIFIC INTERFERONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 219 ASIA PACIFIC INTERFERONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 220 ASIA PACIFIC OTHER DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 221 ASIA PACIFIC OTHER DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 222 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 223 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 224 ASIA PACIFIC HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 225 ASIA PACIFIC HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 226 ASIA PACIFIC ONLINE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 227 ASIA PACIFIC ONLINE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 228 ASIA PACIFIC RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 229 ASIA PACIFIC RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 230 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 231 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 232 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 233 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 234 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 235 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 236 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 237 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 238 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 239 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 240 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 241 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 242 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 243 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 244 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 245 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 246 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 247 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 248 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 249 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 250 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 251 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 252 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 253 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 254 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 255 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 256 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 257 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 258 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 259 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 260 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 261 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 262 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 263 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 264 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 265 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 266 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 267 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 268 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 269 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 270 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 271 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 272 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 273 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 274 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 275 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 276 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 277 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 278 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 279 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 280 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 281 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 282 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 283 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 284 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 285 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 286 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 287 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 288 LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 289 LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 290 LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 291 LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 292 LAMEA RHEUMATIC DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 293 LAMEA RHEUMATIC DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 294 LAMEA DIABETES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 295 LAMEA DIABETES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 296 LAMEA MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 297 LAMEA MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 298 LAMEA INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 299 LAMEA INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 300 LAMEA OTHER INDICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 301 LAMEA OTHER INDICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 302 LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 303 LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 304 LAMEA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 305 LAMEA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 306 LAMEA ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 307 LAMEA ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 308 LAMEA NSAIDS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 309 LAMEA NSAIDS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 310 LAMEA INTERFERONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 311 LAMEA INTERFERONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 312 LAMEA OTHER DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 313 LAMEA OTHER DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 314 LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 315 LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 316 LAMEA HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 317 LAMEA HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 318 LAMEA ONLINE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 319 LAMEA ONLINE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 320 LAMEA RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 321 LAMEA RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 322 LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 323 LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 324 BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 325 BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 326 BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 327 BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 328 BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 329 BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 330 BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 331 BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 332 ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 333 ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 334 ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 335 ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 336 ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 337 ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 338 ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 339 ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 340 UAE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 341 UAE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 342 UAE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 343 UAE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 344 UAE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 345 UAE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 346 UAE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 347 UAE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 348 SAUDI ARABIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 349 SAUDI ARABIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 350 SAUDI ARABIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 351 SAUDI ARABIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 352 SAUDI ARABIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 353 SAUDI ARABIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 354 SAUDI ARABIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 355 SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 356 SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 357 SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 358 SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 359 SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 360 SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 361 SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 362 SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 363 NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 364 NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 365 NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 366 NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 367 NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 368 NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 369 NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 370 NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 371 REST OF LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 372 REST OF LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 373 REST OF LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 374 REST OF LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 375 REST OF LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 376 REST OF LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 377 REST OF LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 378 REST OF LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 379 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 380 KEY INFORMATION – BIO-RAD LABORATORIES, INC.
TABLE 381 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 382 KEY INFORMATION – GLAXOSMITHKLINE PLC (GSK)
TABLE 383 KEY INFORMATION – PFIZER, INC.
TABLE 384 KEY INFORMATION – MERCK & CO., INC.
TABLE 385 KEY INFORMATION – BAYER AG
TABLE 386 KEY INFORMATION – ABBVIE, INC.
TABLE 387 KEY INFORMATION – AMGEN, INC.
TABLE 388 KEY INFORMATION – NOVARTIS AG

List Of Figures

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH